BioPlus Acquisition Stock Forecast - Price Action Indicator
| BIOSWDelisted Stock | USD 0.14 0.00 0.00% |
BioPlus Stock Forecast is based on your current time horizon.
BioPlus |
| Check BioPlus Acquisition Volatility | Backtest BioPlus Acquisition | Information Ratio |
BioPlus Acquisition Trading Date Momentum
| On November 24 2024 BioPlus Acquisition Corp was traded for 0.14 at the closing time. The highest daily price throughout the period was 0.14 and the lowest price was 0.14 . There was no trading activity during the period 0.0. Lack of trading volume on 11/24/2024 did not affect price variability. The overall trading delta to current closing price is 0.00% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
Compare BioPlus Acquisition to competition
BioPlus Acquisition Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioPlus Acquisition stock to make a market-neutral strategy. Peer analysis of BioPlus Acquisition could also be used in its relative valuation, which is a method of valuing BioPlus Acquisition by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BioPlus Acquisition Market Strength Events
Market strength indicators help investors to evaluate how BioPlus Acquisition stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioPlus Acquisition shares will generate the highest return on investment. By undertsting and applying BioPlus Acquisition stock market strength indicators, traders can identify BioPlus Acquisition Corp entry and exit signals to maximize returns.
BioPlus Acquisition Risk Indicators
The analysis of BioPlus Acquisition's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BioPlus Acquisition's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bioplus stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.2 | |||
| Semi Deviation | 7.43 | |||
| Standard Deviation | 11.2 | |||
| Variance | 125.47 | |||
| Downside Variance | 177.39 | |||
| Semi Variance | 55.14 | |||
| Expected Short fall | (13.20) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in BioPlus Stock
If you are still planning to invest in BioPlus Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BioPlus Acquisition's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |